Top compounds associated with response to TIGD2


Feature Type Standardized
Nominal ANOVA
mRNA embelin GDSC1000 pan-cancer AAC -0.057 0.1
mRNA bendamustine CTRPv2 pan-cancer AAC 0.062 0.1
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.053 0.1
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.054 0.1
mRNA VU0155056 CTRPv2 pan-cancer AAC 0.061 0.1
mRNA ML239 CTRPv2 pan-cancer AAC -0.057 0.1
mRNA paclitaxel gCSI pan-cancer AAC -0.082 0.1
mRNA Erlotinib CCLE pan-cancer AAC 0.072 0.1
mRNA SL 0101-1 GDSC1000 pan-cancer AAC 0.058 0.1
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.051 0.1
Download CSV